Getinge has signed a temporary agreement with Scania CV AB on personnel support during 2020. Until year-end, Getinge will temporary hire a limited number of Scania personnel to support the needed ramp up of ventilator production at Getinge’s production site in Solna, Sweden.
On March 17 and April 6, Getinge announced an increased production of ventilators for intensive care units. To ensure a smooth ramp up of the production, Getinge has entered into a partnership agreement with Scania, covering temporary hire of Scania personnel to support Getinge’s ongoing ramp up of its ventilator production. The hired personnel will mainly support Getinge’s suppliers to ramp up their production, as well as support the production of ventilators, which previously has been communicated by Scania.
“I am happy that we can enter this partnership with Scania”, says Elin Frostehav, Vice President Critical Care at Getinge. “The collaboration is beneficial for both companies as Getinge can offer temporary work for permitted staff and Scania can share their experience and knowledge within logistical flows at our suppliers.”
The partnership agreement is valid between April 1st and December 31st 2020. It is estimated that approximately 30 persons will temporary transfer to Getinge from Scania.
Getinge welcomes all types of collaborations that can contribute to a sustainable production and is very positive to the many companies and organizations that are reaching out and want to support caregivers save lives.
Anna Appelqvist, Vice President Corporate Communications
Phone: + 46 (0) 734 244 527
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.